chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination complication, Vaccination site erythema, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of URTICARIA (Broke out into hives), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE RASH (rash on right arm) and VACCINATION SITE ERYTHEMA (Big red circle around her arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, the patient experienced URTICARIA (Broke out into hives), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE RASH (rash on right arm) and VACCINATION SITE ERYTHEMA (Big red circle around her arm). The patient was treated with ACRIVASTINE (BENADRYL ALLERGY RELIEF) on 09-Aug-2021 for Adverse reaction, at an unspecified dose and frequency. On 11-Aug-2021, URTICARIA (Broke out into hives), VACCINATION COMPLICATION (Covid arm), VACCINATION SITE RASH (rash on right arm) and VACCINATION SITE ERYTHEMA (Big red circle around her arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I have severe dizziness/Lightheadedness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I have severe dizziness/Lightheadedness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I have severe dizziness/Lightheadedness). At the time of the report, DIZZINESS (I have severe dizziness/Lightheadedness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by reporter. No treatment details were provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: received the first dose of the Moderna COVID-19 Vaccine in June and wanted to know what would be the best time to get the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (received the first dose of the Moderna COVID-19 Vaccine in June and wanted to know what would be the best time to get the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (received the first dose of the Moderna COVID-19 Vaccine in June and wanted to know what would be the best time to get the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (received the first dose of the Moderna COVID-19 Vaccine in June and wanted to know what would be the best time to get the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concurrent and treatment medication was reported by patient
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache nonstop; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache nonstop) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jul-2021, the patient experienced HEADACHE (headache nonstop). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache nonstop) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Lip swelling, Mouth swelling, Swelling face
Clinical narrative: it was also drying out her eyes; I still Have mouth swelling; I had swelling in my face / I had swelling in my lower jaw / I had swelling in my cheeks; I also had swelling in my upper lip; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH SWELLING (I still Have mouth swelling), SWELLING FACE (I had swelling in my face / I had swelling in my lower jaw / I had swelling in my cheeks), LIP SWELLING (I also had swelling in my upper lip) and DRY EYE (it was also drying out her eyes) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Dermal filler injection (The patient got fillers in her face, lower jaw and cheeks) on 17-Feb-2021 and Dermal filler injection (The patient got fillers in her upper lip well over one year prior) in 2020.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced SWELLING FACE (I had swelling in my face / I had swelling in my lower jaw / I had swelling in my cheeks) and LIP SWELLING (I also had swelling in my upper lip). On 20-Aug-2021, the patient experienced MOUTH SWELLING (I still Have mouth swelling). On an unknown date, the patient experienced DRY EYE (it was also drying out her eyes). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form. At the time of the report, MOUTH SWELLING (I still Have mouth swelling) had not resolved and SWELLING FACE (I had swelling in my face / I had swelling in my lower jaw / I had swelling in my cheeks), LIP SWELLING (I also had swelling in my upper lip) and DRY EYE (it was also drying out her eyes) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Osteitis, Vaccination site inflammation, Vaccination site warmth
Clinical narrative: jaw was inflamed; Head ache in the eye region and back of the skull; Warm sensation at the site of the injection.; Inflammation at the site of the injection.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm sensation at the site of the injection.), VACCINATION SITE INFLAMMATION (Inflammation at the site of the injection.), OSTEITIS (jaw was inflamed) and HEADACHE (Head ache in the eye region and back of the skull) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Warm sensation at the site of the injection.), VACCINATION SITE INFLAMMATION (Inflammation at the site of the injection.) and HEADACHE (Head ache in the eye region and back of the skull). On an unknown date, the patient experienced OSTEITIS (jaw was inflamed). On 21-Aug-2021, HEADACHE (Head ache in the eye region and back of the skull) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm sensation at the site of the injection.), VACCINATION SITE INFLAMMATION (Inflammation at the site of the injection.) and OSTEITIS (jaw was inflamed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by the reporter. No treatment medication were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: a rash on the arm where the first dose was administered / a rash an allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (a rash on the arm where the first dose was administered / a rash an allergic reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (a rash on the arm where the first dose was administered / a rash an allergic reaction). At the time of the report, VACCINATION SITE RASH (a rash on the arm where the first dose was administered / a rash an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Haemoptysis, Influenza like illness
Clinical narrative: Slept almost all day, all night; Had symptoms like the flu for like a week after she took the first shot; Was just real fatigued; Low grade fever like a 99.5/Had fever; Coughing; Coughing a blood; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), HAEMOPTYSIS (Coughing a blood), SOMNOLENCE (Slept almost all day, all night), INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) and PYREXIA (Low grade fever like a 99.5/Had fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced COUGH (Coughing), HAEMOPTYSIS (Coughing a blood) and PYREXIA (Low grade fever like a 99.5/Had fever). On an unknown date, the patient experienced SOMNOLENCE (Slept almost all day, all night), INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) and FATIGUE (Was just real fatigued). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (Coughing), HAEMOPTYSIS (Coughing a blood) and PYREXIA (Low grade fever like a 99.5/Had fever) had not resolved, SOMNOLENCE (Slept almost all day, all night) and FATIGUE (Was just real fatigued) outcome was unknown and INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Body temperature: 99.5 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Patient stated that she was exposed to it probably about 8 days ago. However, she was not coughing a lot, it was not tremendous and it was not constant. Patient was scheduled for her second dose tomorrow but she was not sure about taking it and wanted to find out if she should take it or postpone until she got better.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence
Clinical narrative: Slept almost all day, all night; Had symptoms like the flu for like a week after she took the first shot; Was just real fatigued; Low grade fever like a 99.5/Had fever; Coughing; Coughing a blood; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), HAEMOPTYSIS (Coughing a blood), SOMNOLENCE (Slept almost all day, all night), INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) and PYREXIA (Low grade fever like a 99.5/Had fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced COUGH (Coughing), HAEMOPTYSIS (Coughing a blood) and PYREXIA (Low grade fever like a 99.5/Had fever). On an unknown date, the patient experienced SOMNOLENCE (Slept almost all day, all night), INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) and FATIGUE (Was just real fatigued). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (Coughing), HAEMOPTYSIS (Coughing a blood) and PYREXIA (Low grade fever like a 99.5/Had fever) had not resolved, SOMNOLENCE (Slept almost all day, all night) and FATIGUE (Was just real fatigued) outcome was unknown and INFLUENZA LIKE ILLNESS (Had symptoms like the flu for like a week after she took the first shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Body temperature: 99.5 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Patient stated that she was exposed to it probably about 8 days ago. However, she was not coughing a lot, it was not tremendous and it was not constant. Patient was scheduled for her second dose tomorrow but she was not sure about taking it and wanted to find out if she should take it or postpone until she got better.   Reporter did not allow further contact
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Myalgia
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (The patient stated "fell kind of dizzy".), CHILLS (Chills) and MYALGIA (Body ache) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced DIZZINESS (The patient stated "fell kind of dizzy".), CHILLS (Chills) and MYALGIA (Body ache). At the time of the report, DIZZINESS (The patient stated "fell kind of dizzy".), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: had a fever with a temperature of 99.8 F earlier & has one of 100.2 F right now; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (had a fever with a temperature of 99.8 F earlier & has one of 100.2 F right now) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (had a fever with a temperature of 99.8 F earlier & has one of 100.2 F right now). At the time of the report, PYREXIA (had a fever with a temperature of 99.8 F earlier & has one of 100.2 F right now) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) temperature of 99.8 F earlier & has one of 100.2 F right now.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant drugs were reported.  No Treatment information  were reported.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in left arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in left arm). At the time of the report, PAIN IN EXTREMITY (Soreness in left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment information was not provided.   Reporter did not allow further contact
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 12 year old received her first dose of the Moderna; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received her first dose of the Moderna) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received her first dose of the Moderna). On 20-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received her first dose of the Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-292978, MOD-2021-293498 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided.  Treatment information was not provided.  It was reported that her brother also got the same side effect. Side effect: Shingles.   This case was linked to MOD-2021-293374 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: Got 3rd dose; She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 046A21A and 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021). On 18-Aug-2021, EXTRA DOSE ADMINISTERED (Got 3rd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She and her husband have both received 3 doses of the moderna covid-19 vaccine by injection on 17FEB2021 (023M20A), 19MAR2021 (046A21A), and 18AUG2021) had resolved.            No concomitant and treatment medication was reported by patient.  Patient reported that she was not immunocompromised. Patients had not experienced any other side effects.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information were not provided by the reporter. Concomitant medications were not reported by reporter.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Fourth vaccination on 21-JUL-2021/Four doses of moderna; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Fourth vaccination on 21-JUL-2021/Four doses of moderna) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXTRA DOSE ADMINISTERED (Fourth vaccination on 21-JUL-2021/Four doses of moderna). At the time of the report, EXTRA DOSE ADMINISTERED (Fourth vaccination on 21-JUL-2021/Four doses of moderna) had resolved.            Concomitant medication was not provided Treatment information was not reported   This case was linked to MOD-2021-265485 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  This report is for patient #2   This case was linked to MOD-2021-133518, MOD-2021-133557, MOD-2021-133558 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph nodes swelling; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes swelling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes swelling). At the time of the report, LYMPHADENOPATHY (lymph nodes swelling) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Relevant concomitant medications were not provided.  Treatment information was not provided.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: administered Higher dose ( 1 ml ) -than-authorized dose ( 0.5 Ml ); This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (administered Higher dose ( 1 ml ) -than-authorized dose ( 0.5 Ml )) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (administered Higher dose ( 1 ml ) -than-authorized dose ( 0.5 Ml )). At the time of the report, ACCIDENTAL OVERDOSE (administered Higher dose ( 1 ml ) -than-authorized dose ( 0.5 Ml )) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment information was provided.   This case was linked to MOD-2021-293191, MOD-2021-293335 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Running fever during the night 101; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Running fever during the night 101) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Running fever during the night 101). At the time of the report, PYREXIA (Running fever during the night 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) Running fever during the night 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was reported by reporter.   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for covid; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (tested positive for covid) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced COVID-19 (tested positive for covid). At the time of the report, COVID-19 (tested positive for covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Oropharyngeal pain
Clinical narrative: sore throat; chills; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and CHILLS (chills). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and CHILLS (chills) outcome was unknown.            No Concomitant medications were provided.  No Treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: flu like symptoms; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported. Treatment medication were not reported.  This morning, the patient had the weak/tired Covid-19 feeling when the patient had it in May. Now the patient is very nauseated, The patient have a grandson with a fever, one with flu like symptoms, son-in-law same.  The patient's husband and daughter are so far fine.  How long does this last  This report 1s for patient# 3   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in the ear; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in the ear) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in the ear). At the time of the report, TINNITUS (ringing in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Feeling hot, Musculoskeletal stiffness, Vaccination site pain, Vaccination site warmth
Clinical narrative: heat from site to face; heat from site to face; stiffness in site hand; pain at shot site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (heat from site to face), FEELING HOT (heat from site to face), MUSCULOSKELETAL STIFFNESS (stiffness in site hand) and VACCINATION SITE PAIN (pain at shot site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (heat from site to face), FEELING HOT (heat from site to face), MUSCULOSKELETAL STIFFNESS (stiffness in site hand) and VACCINATION SITE PAIN (pain at shot site). At the time of the report, VACCINATION SITE WARMTH (heat from site to face), FEELING HOT (heat from site to face), MUSCULOSKELETAL STIFFNESS (stiffness in site hand) and VACCINATION SITE PAIN (pain at shot site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Top of my chest was kind of heavy, from my chest to my throat and nose; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Top of my chest was kind of heavy, from my chest to my throat and nose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Top of my chest was kind of heavy, from my chest to my throat and nose). At the time of the report, CHEST DISCOMFORT (Top of my chest was kind of heavy, from my chest to my throat and nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by reporter. No treatment details were provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Felt really tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt really tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced FATIGUE (Felt really tired). At the time of the report, FATIGUE (Felt really tired) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-293529 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Arm in a lot of pain; Can't lift the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm). At the time of the report, PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st dose given on 15Apr2021; no 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose given on 15Apr2021; no 2nd dose yet) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose given on 15Apr2021; no 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose given on 15Apr2021; no 2nd dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter. Treatment information was not provided.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 38 days between 1st and 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (38 days between 1st and 2nd dose) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (38 days between 1st and 2nd dose). On 01-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (38 days between 1st and 2nd dose) had resolved.            No concomitant medications were reported.  No Treatment information was provided.   This case was linked to MOD21-133817 (E2B Linked Report).; Sender's Comments:  MOD21-133817:
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Report a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report a side effect). At the time of the report, VACCINATION COMPLICATION (Report a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided by the reporter.   No treatment information was provided by the reporter.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Insomnia
Clinical narrative: Woke up on and off all night; Terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Woke up on and off all night) and HEADACHE (Terrible headache) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A, 032L20A and 049C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), METOPROLOL, DIAZEPAM (VALIUM), METFORMIN, TERAZOSIN HYDROCHLORIDE (HYTRIN) and LEVOTHYROXINE for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Aug-2021, the patient experienced INSOMNIA (Woke up on and off all night) and HEADACHE (Terrible headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, Insomnia and Body temperature, at an unspecified dose and frequency. At the time of the report, INSOMNIA (Woke up on and off all night) and HEADACHE (Terrible headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Aug-2021, Body temperature: inconclusive (High) Inconclusive.         Again started fever on 20-Aug-2021 morning.  Concomitant medication also included Blood thinner.   This case was linked to MOD-2021-005974 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Extra dose administered, Fatigue, Hyperhidrosis, Malaise
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Extra dose), VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck) and MALAISE (just didn't feel well) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Extra dose). On 16-Aug-2021, the patient experienced VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck) and ARTHRALGIA (pain went into my shoulder). On 17-Aug-2021, the patient experienced MALAISE (just didn't feel well), TENSION HEADACHE (tightness in her head) and HYPERHIDROSIS (broke out in perspiration in my scalp and face). On 20-Aug-2021, the patient experienced FATIGUE (tired). On an unknown date, the patient experienced PYREXIA (a little fever). The patient was treated with LORATADINE (CLARITINE) on 19-Aug-2021 at an unspecified dose and frequency. On 15-Aug-2021, EXTRA DOSE ADMINISTERED (Extra dose) had resolved, FATIGUE (tired) had resolved. At the time of the report, VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck), MALAISE (just didn't feel well), TENSION HEADACHE (tightness in her head), HYPERHIDROSIS (broke out in perspiration in my scalp and face), ARTHRALGIA (pain went into my shoulder) and PYREXIA (a little fever) outcome was unknown.            This case was linked to MOD-2021-293599 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Neck pain, Pyrexia, Tension headache, Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Extra dose), VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck) and MALAISE (just didn't feel well) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Extra dose). On 16-Aug-2021, the patient experienced VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck) and ARTHRALGIA (pain went into my shoulder). On 17-Aug-2021, the patient experienced MALAISE (just didn't feel well), TENSION HEADACHE (tightness in her head) and HYPERHIDROSIS (broke out in perspiration in my scalp and face). On 20-Aug-2021, the patient experienced FATIGUE (tired). On an unknown date, the patient experienced PYREXIA (a little fever). The patient was treated with LORATADINE (CLARITINE) on 19-Aug-2021 at an unspecified dose and frequency. On 15-Aug-2021, EXTRA DOSE ADMINISTERED (Extra dose) had resolved, FATIGUE (tired) had resolved. At the time of the report, VACCINATION COMPLICATION (COVID arm/It was pretty bad, it looked bad, it felt bad), MIGRAINE (almost a migraine headache), NECK PAIN (pain went into my neck), MALAISE (just didn't feel well), TENSION HEADACHE (tightness in her head), HYPERHIDROSIS (broke out in perspiration in my scalp and face), ARTHRALGIA (pain went into my shoulder) and PYREXIA (a little fever) outcome was unknown.            This case was linked to MOD-2021-293599 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Myalgic encephalitis sufferers anecdotally experienced a reduction in symptoms after receiving an mRNA vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Unusual reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unusual reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unusual reaction). At the time of the report, VACCINATION COMPLICATION (Unusual reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment medications were not reported.  The patient concerned about getting the second dose because, Patient had an unusual reaction to the first dose.